My site

BEDFORD, Mass. - Friday, 05. September 2025

(BUSINESS WIRE)--RSA, the security-first identity leader, backed by Clearlake Capital Group, L.P. (together with its affiliates) and STG, today announced that Greg Nelson, current President and Chief Business Officer, will succeed Rohit Ghai as Chief Executive Officer on September 15, 2025. Mr. Ghai will transition to a strategic advisory role after serving almost eight years as CEO.

Mr. Nelson, a seasoned SaaS executive who has more than 30 years of software, data, technology and private equity experience, is expected to lead RSA into this next phase of accelerated growth. The company’s strategic growth initiatives and investments will focus on:

Passwordless – Eliminating reliance on passwords to improve security and user experience
Artificial Intelligence (AI) – Leveraging AI to enhance threat detection, prevention, and response
Posture Management – Strengthening governan ... Read more »

− Approval Expands Use of VONVENDI to Include Routine Prophylaxis to Reduce the Frequency of Bleeding Episodes in Adults with Type 1 and 2 Von Willebrand Disease (VWD) and On-Demand and Perioperative Management of Bleeding in Pediatric Patients with VWD1− VONVENDI is the Only Recombinant Von Willebrand Factor Replacement Therapy with Approved Indications in Adults and Children with VWD1− VWD, the Most Common Bleeding Disorder, Impacts More Than 3 Million People in the U.S.2 (BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for VONVENDI® [von Willebrand factor (Recombinant)], expanding the indication to include routine prophylaxis to reduce the frequency of bleeding episodes in adults with von Willebrand Disease (VWD), including those with Type 1 and 2 disease, and on-demand and perioperative management of bleeding in pediatric patients with VWD. VONVENDI was pre ... Read more »

MILPITAS, Calif. - Friday, 05. September 2025 AETOSWire 

 

(BUSINESS WIRE)--Zepp Health (NYSE: ZEPP), the parent company of Amazfit, today announced it has acquired the core assets and intellectual property of Wild.AI, a pioneering women’s wellness platform focused on optimizing female performance through hormone-informed coaching. The acquisition was completed at the end of August and includes Wild.AI’s proprietary technology and select members of its leadership team.

Wild.AI is renowned for using physiological and hormonal data to help women Track, Train, Fuel, and Recover based on their cycle and life stage. From menstruation to menopause, the platform delivers personalized insights that help improve performance, reduce injury risk, and deepen body awareness—serving both elite athletes and everyday fitness enthusiasts.

This acquisition builds on a successful partnership between Zepp Health and Wild.AI, including t ... Read more »

NUREMBERG, Germany - Friday, 05. September 2025 AETOSWire Print 

GfKnewron® Consumer enhancement delivers the consumer voice - decoding consumer verbatims into actionable insights for brands and retailers

Integrated with one of the largest recent buyer studies for Technology and Durables, capturing over 1 billion annual volume sales

 

(BUSINESS WIRE)--NielsenIQ (NIQ) (NYSE: NIQ), a leading global consumer intelligence company, today announced an enhancement of its GfKnewron® Consumer platform, now including AI-Powered Shopper Voice. The market, consumer, and brand intelligence platform now delivers the consumer voice in their own words – shopper’s verbatim comments about a brand, its retail partners, and potential competitors. By integrating the largest recent buyer survey for Tech & Durables with NIQ's robust point-of-sale tracking data, ... Read more »